Literature DB >> 20669865

Potential adverse effects of discontinuing psychotropic drugs. Part 3: Antipsychotic, dopaminergic, and mood-stabilizing drugs.

Robert H Howland1.   

Abstract

Abrupt discontinuation of antipsychotic drugs in patients with schizophrenia is associated with earlier, and often more severe, illness episodes than are seen with gradual discontinuation. Antipsychotic drugs can cause various abnormal motor syndromes, but abruptly stopping them has been associated with the seemingly paradoxical development of similar motor syndromes, such as withdrawal dyskinesias, parkinsonian symptoms, dystonias, and neuroleptic malignant syndrome. Dopamine-releasing and dopamine-agonist drugs are used to treat some of the motor syndromes caused by antipsychotic drugs, but their abrupt discontinuation can also be associated with abnormal syndromes. When antipsychotic drugs, lithium, or certain anticonvulsant drugs are used for treatment of bipolar disorder, rapid versus gradual discontinuation is more likely to lead to greater mood instability and manic relapse. If necessary, these medications should be gradually tapered to minimize all types of adverse discontinuation effects. Patients should be educated about the possible adverse effects of abrupt medication discontinuation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20669865     DOI: 10.3928/02793695-20100708-01

Source DB:  PubMed          Journal:  J Psychosoc Nurs Ment Health Serv        ISSN: 0279-3695            Impact factor:   1.098


  2 in total

1.  Physical Health Outcomes in Preschoolers with Prior Authorization for Antipsychotics.

Authors:  Yu-Jung Wei; Xinyue Liu; Nikhil Rao; Marie McPherson; Mary Beth Jones; Regina Bussing; Almut G Winterstein
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-07-14       Impact factor: 2.576

2.  The Monash Autism-ADHD genetics and neurodevelopment (MAGNET) project design and methodologies: a dimensional approach to understanding neurobiological and genetic aetiology.

Authors:  Rachael Knott; Beth P Johnson; Jeggan Tiego; Olivia Mellahn; Amy Finlay; Kathryn Kallady; Maria Kouspos; Vishnu Priya Mohanakumar Sindhu; Ziarih Hawi; Aurina Arnatkeviciute; Tracey Chau; Dalia Maron; Emily-Clare Mercieca; Kirsten Furley; Katrina Harris; Katrina Williams; Alexandra Ure; Alex Fornito; Kylie Gray; David Coghill; Ann Nicholson; Dinh Phung; Eva Loth; Luke Mason; Declan Murphy; Jan Buitelaar; Mark A Bellgrove
Journal:  Mol Autism       Date:  2021-08-05       Impact factor: 7.509

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.